Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating the effects of vitamin D and calcium on women who have gestational diabetes, a type of diabetes that develops during pregnancy. The goal is to see if taking these supplements can help manage blood sugar levels and improve cholesterol profiles, which are important for both the mother’s and baby’s health. The study will measure key indicators like fasting blood sugar and cholesterol levels to understand how these supplements might influence pregnancy outcomes.

To participate in this trial, women aged 18 to 40 who are between 24 and 28 weeks pregnant and have been diagnosed with gestational diabetes are eligible. Participants will need to provide written consent and should not have any pre-existing diabetes or other serious health issues. Throughout the study, participants can expect to receive careful monitoring and support while contributing to important research that could benefit future mothers and their babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women aged 18-40 years.
• • Gestational age between 24-28 weeks.
• • Diagnosis of GDM based on OGTT results.
• • Willingness of participants to provide written informed consent.
• Exclusion Criteria:
• • Pre-existing diabetes mellitus (type 1 or type 2).
• • Chronic kidney or liver disease.
• • Use of vitamin D or calcium supplements in the last 3 months.
• • Multiple pregnancies (twins, triplets).
• • Any major pregnancy complications (e.g., preeclampsia).

Trial Officials